Difficulty: Medium
Average Score: 82%
Practice
For which type of malignancy should the nurse expect the use of the intravesical route of regional chemotherapy delivery?
Correct answer
A
Rationale
In the context of pharmacology and regional chemotherapy delivery, the correct answer is A) Bladder. Intravesical route refers to the administration of drugs directly into the bladder, making it an ideal route for treating bladder malignancies. The rationale behind this choice lies in the proximity of the drug delivery to the site of action, maximizing drug concentration in the bladder while minimizing systemic exposure and side effects.
Option B) Leukemia is incorrect because leukemia is a systemic malignancy that affects the bone marrow and blood, making intravesical delivery irrelevant for this type of malignancy.
Option C) Osteogenic sarcoma is incorrect because this type of malignancy originates in the bones, and intravesical delivery is not suitable for treating bone-related cancers.
Option D) Metastasis to the brain is incorrect as intravesical delivery is not used to treat brain metastases. The blood-brain barrier limits the passage of drugs into the brain, necessitating other routes of administration.
Educationally, understanding the rationale behind choosing the correct route of drug administration based on the type and location of malignancy is crucial for healthcare professionals. It ensures effective and targeted treatment while minimizing systemic side effects. This knowledge enhances patient care and outcomes by optimizing the therapeutic benefits of chemotherapy.
Option B) Leukemia is incorrect because leukemia is a systemic malignancy that affects the bone marrow and blood, making intravesical delivery irrelevant for this type of malignancy.
Option C) Osteogenic sarcoma is incorrect because this type of malignancy originates in the bones, and intravesical delivery is not suitable for treating bone-related cancers.
Option D) Metastasis to the brain is incorrect as intravesical delivery is not used to treat brain metastases. The blood-brain barrier limits the passage of drugs into the brain, necessitating other routes of administration.
Educationally, understanding the rationale behind choosing the correct route of drug administration based on the type and location of malignancy is crucial for healthcare professionals. It ensures effective and targeted treatment while minimizing systemic side effects. This knowledge enhances patient care and outcomes by optimizing the therapeutic benefits of chemotherapy.